A new therapeutic target in pulmonary hypertension is identified in an experimental model

by Fundació Clínic per a la Recerca Biomèdica

Researchers at the hospital Clínic Barcelona-IDIBAPS and CIBERES show that the inhibition of survivin, an anti-apoptotic protein, improves pulmonary hypertension in an experimental model.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream